Greg Newman
Member since: Sep '11
Director & Portfolio Manager at
Scotia Wealth Management
Scotia Wealth Management
1841 Opinions
Latest Top Picks
A quality stock that is poised to benefit from the reopening. Same store sales were up 5% in China. They are overcoming fewer transactions with offsetting bigger baskets. 2021 outlook was raised. 48% EPS growth trading at 25x 2023 valuation. Pays a reasonable dividend. (Analysts’ price target is $108.84)
The Clearwater acquisition offers good synergy. The partnership makes the deal less capital intensive. Part of the recovery trade with restaurant and hotel sales coming back. 22% EPS growth trading at 18x. Have made very good acquisitions and is good at integrating them. (Analysts’ price target is $116.82)
Doesn't want to add more risk if there is no need. The RSA purchase gives them greater scale, distribution and more avenues for growth. Synergistic. The market is waiting to see results. The stock will rerate with results. Good to grow quiet wealth. (Analysts’ price target is $176.00)
(A Top Pick Jan 10/20, Up 19%) There is definite headwinds with regulatory oversight but there is still runway. Growth rate is around 20% and trading around 21x 2022. Price to growth, it is fine. Monthly active users just beat expectations. Average revenue per user is $10. A name you want to buy into asides the regulatory risk.
(A Top Pick Jan 10/20, Up 70%) Would wait for a pullback to put fresh money into it. Trading at 50x with a growth rate of 36%. Price to growth, it is not horrible given its dominance. A global utility to our way of life. A necessary.
Signal
Opinion
Expert
Chart
COMMENT
COMMENT
January 29, 2021
Market outlook. The vaccines are coming slower than we would like. It is a persistent virus but it is a natural event. In terms of the Reddit frenzy, we have seen this before but not to the same extent. He got lucky and sold into this rally for BB. Robinhood had to suspend to ensure solvency. Buyer beware when the market itself is threatened.
Show full opinionHide full opinion
Market outlook. The vaccines are coming slower than we would like. It is a persistent virus but it is a natural event. In terms of the Reddit frenzy, we have seen this before but not to the same extent. He got lucky and sold into this rally for BB. Robinhood had to suspend to ensure solvency. Buyer beware when the market itself is threatened.
COMMENT
COMMENT
January 29, 2021
Robinhood. People are engaged now and after 2008, there was virtually no retail investors. They are slowly coming back, and more liquidity is a good thing. Democratization of ideas is also a good thing. The market mechanism is to find truth. Stories can persist for a while but it will reflect the truth eventually. Hopefully people won't be burnt too badly.
Show full opinionHide full opinionRobinhood. People are engaged now and after 2008, there was virtually no retail investors. They are slowly coming back, and more liquidity is a good thing. Democratization of ideas is also a good thing. The market mechanism is to find truth. Stories can persist for a while but it will reflect the truth eventually. Hopefully people won't be burnt too badly.
SELL STRENGTH
SELL STRENGTH
January 29, 2021
There were some fundamental winds that were positive in the past couple months. Notably, the Amazon deal, Facebook settlement and patent sales. Balance sheet is also pretty strong. However, it has totally gotten sucked into the Reddit speculation. It remains a speculative story still.
electrical/electronic
BUY WEAKNESS
BUY WEAKNESS
January 29, 2021
Some bad news for AC today in regards to travel restrictions. It depends on vaccines and how long their balance sheet can last. There is pent-up demand. There is just the question of whether business travel will come back to the same extent. It is a recovery trade however. It is still not cheap at these levels. It is starting to get to a level where you can buy some.
Show full opinionHide full opinionSome bad news for AC today in regards to travel restrictions. It depends on vaccines and how long their balance sheet can last. There is pent-up demand. There is just the question of whether business travel will come back to the same extent. It is a recovery trade however. It is still not cheap at these levels. It is starting to get to a level where you can buy some.
Transportation
BUY WEAKNESS
BUY WEAKNESS
January 29, 2021
A wild stock. They have been having some production troubles combined with methanol prices coming down. It is a whippy stock. It is part of the recovery trade and you could inch in a little bit more.
A wild stock. They have been having some production troubles combined with methanol prices coming down. It is a whippy stock. It is part of the recovery trade and you could inch in a little bit more.
chemicals
COMMENT
COMMENT
January 29, 2021
It is quite expensive though it is good. Earnings dissapointed a little on guidance. EPS should grow at 11%. The name is trading at 23x 2021 earnings. CP may be a better buy in terms of valuation.
It is quite expensive though it is good. Earnings dissapointed a little on guidance. EPS should grow at 11%. The name is trading at 23x 2021 earnings. CP may be a better buy in terms of valuation.
Transportation
BUY
BUY
January 29, 2021
Their recent acquisition positions them as a leading environmental consulting firm. Right now, it is trading at 27x 2022 earnings. However, they are modelling 33% EPS growth. On a price to growth basis, it is a compelling name. You can still enter at these levels.
Show full opinionHide full opinionTheir recent acquisition positions them as a leading environmental consulting firm. Right now, it is trading at 27x 2022 earnings. However, they are modelling 33% EPS growth. On a price to growth basis, it is a compelling name. You can still enter at these levels.
Business Services
BUY
BUY
January 29, 2021
They have not done well over the past few years. A contrarian trade. However, he started buying into it 2-3 months ago for return of value. Pretty cheap at 1.8x book value or 34% discount to peers. Underwriting leverage should help them. This moves on the investment merits and they have done well with BB. It probably has some good runway here.
They have not done well over the past few years. A contrarian trade. However, he started buying into it 2-3 months ago for return of value. Pretty cheap at 1.8x book value or 34% discount to peers. Underwriting leverage should help them. This moves on the investment merits and they have done well with BB. It probably has some good runway here.
insurance
DON'T BUY
DON'T BUY
January 29, 2021
A must own name. Last quarter their earnings beat revenues with 43% profit margins. It has had a huge move. 15% compound annual growth, trading at 38x 2022 earnings. It is pricey so you could see some pull back around ~$30-$40 below current levels when the market cycles into value.
Show full opinionHide full opinionA must own name. Last quarter their earnings beat revenues with 43% profit margins. It has had a huge move. 15% compound annual growth, trading at 38x 2022 earnings. It is pricey so you could see some pull back around ~$30-$40 below current levels when the market cycles into value.
computer software/processing
BUY
BUY
January 29, 2021
It has been correcting similar to other copper stocks. You want to see some healthy corrections so this is normal. Earnings are set for this week. Copper is part of the green energy solution and should profit from infrastructure spending. A name that he likes and this is the time to own names like this.
Show full opinionHide full opinionIt has been correcting similar to other copper stocks. You want to see some healthy corrections so this is normal. Earnings are set for this week. Copper is part of the green energy solution and should profit from infrastructure spending. A name that he likes and this is the time to own names like this.
precious metals
BUY WEAKNESS
BUY WEAKNESS
January 29, 2021
Very strong sales with low inventory. It is at 12x 2021 evaluation that makes it a compelling name. There is a lot of life left in the stock with 34% growth rate. You want to add more in retracements. 20%-30% upside in the next few years.
Show full opinionHide full opinionVery strong sales with low inventory. It is at 12x 2021 evaluation that makes it a compelling name. There is a lot of life left in the stock with 34% growth rate. You want to add more in retracements. 20%-30% upside in the next few years.
Automotive
BUY
BUY
January 29, 2021
Would buy at these prices. They are trying to ramp up their copper which is positive. A good place to be. The stock is not expensive right now, and it is one of the best in the space to buy right now.
Show full opinionHide full opinionWould buy at these prices. They are trying to ramp up their copper which is positive. A good place to be. The stock is not expensive right now, and it is one of the best in the space to buy right now.
Mining
HOLD
HOLD
January 29, 2021
Decent valuation at 13x 2021. Modelling 2021 earnings being 10% higher than last year. It pays a dividend to pay. Always a question on backlog. China was trying to buy this asset around $19. Can have a meaningful upside since it is not too crowded. Continue to hold it.
Show full opinionHide full opinionDecent valuation at 13x 2021. Modelling 2021 earnings being 10% higher than last year. It pays a dividend to pay. Always a question on backlog. China was trying to buy this asset around $19. Can have a meaningful upside since it is not too crowded. Continue to hold it.
contractors
BUY
BUY
January 29, 2021
It has good value here. Free cash yield is 13%. PE is around 13-14x. Growth rate is around 9%. It moves around 25% of oil and natural gas in NA. They are trying to pivot to renewables too. You can expect a nice total return, especially with the dividend.
Show full opinionHide full opinionIt has good value here. Free cash yield is 13%. PE is around 13-14x. Growth rate is around 9%. It moves around 25% of oil and natural gas in NA. They are trying to pivot to renewables too. You can expect a nice total return, especially with the dividend.
oil/gas pipelines
BUY WEAKNESS
BUY WEAKNESS
January 29, 2021
Trading at 45x 2022 which is not obscene. Modelling a 33% EPS growth. Price-to-growth not bad. They beat Q3 expectations. An essential service for AI, processing power, etc. There is some cyclical elements. Try to buy at lower levels, but it is okay to buy now.
Show full opinionHide full opinionTrading at 45x 2022 which is not obscene. Modelling a 33% EPS growth. Price-to-growth not bad. They beat Q3 expectations. An essential service for AI, processing power, etc. There is some cyclical elements. Try to buy at lower levels, but it is okay to buy now.
computer software/processing
PixFuture exclusive partner.
© Stockchase Inc.